Cyanocobalamin Injection — Class II drug recall D-0600-2024
Terminated recall by Zydus Pharmaceuticals (USA) Inc, reported 2024-07-24, distributed in TN. Presence of particulate matter: glass
| Recall number | D-0600-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc, Pennington, NJ, United States |
| Recall initiated | 2024-06-27 |
| Classified | 2024-07-16 |
| Reported by FDA | 2024-07-24 |
| Terminated | 2025-09-04 |
| Distributed | TN |
| Quantity | 432,250 vials |
| Reason classes | foreign material, specification failure |
| NDC | 16714-0165-01 |
| Lot numbers | L200253, L200281, L200301 |
| Expiration dates | 2024-07-31 |
Product
Cyanocobalamin Injection, USP, 1,000mcg/mL, 1 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN, 38141, Mfd. in India, NDC 16714-165-01.
Reason for recall
Presence of particulate matter: glass
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0600-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.